About this event
Epigenetic regulation is profoundly complex – varying across cell types, biological contexts, and time. This complexity creates a significant challenge for researchers who are aiming to generate consistent, interpretable data. Yet, it is within this variability that new diagnostic and therapeutic opportunities are emerging.
How can cutting-edge technologies help us unravel the dynamic, heterogeneous epigenome to reveal disease mechanisms, improve early diagnosis through biomarkers, and identify novel therapeutic targets?
Register for the upcoming webinar series: Unlocking the Epigenome: Precision Tools for Complex Disease to:
Thursday 5th June 2025 at 3pm BST / 4pm CEST/ 10am ET
Join us for our first epigenetics webinar of the series, where we will hear about different methodologies and technologies being used by experts in the field to study the heterogenous and dynamic nature of the epigenome.
Talk 1: Mapping the human body methylome and 3D genome, cell by cell
Jingtian Zhou, Principal Investigator, Arc Institute
Talk 2: Using the 6-base genome to decode health and disease at the single-base resolution
Andrada Tomoni, Product Manager, biomodal
Talk 3: Epigenetic mechanisms underlying metabolic disease
Zong Wei, Associate Professor of Physiology, Mayo Clinic
Talk 4: DNA methylation patterns associated with cancer risk and aging
Chiara Herzog, King’s Prize Fellow (Junior Group Leader), King’s College London
Thursday 12th June at 3pm BST / 4pm CEST/ 10am ET
This session explores the epigenetic foundations of cancer, examining how epigenetic changes influence tumour behaviour and their role in prognosis and treatment.
Talk 1: The role of Polycomb proteins and 3D genomic architecture in epigenetic inheritance and cancer
Giacomo Cavalli, Principal Investigator, Centre National de la Recherche Scientifique
Talk 2: Investigating the oncogenic role of histone acetyltransferase fusions in AML
Alex Radzisheuskaya, Group Leader, The Institute of Cancer Research
Talk 3: Sub-type specific non-coding RNAs that contribute to epigenetic heterogeneity & prognosis in breast cancer
Sankari Nagarajan, Lecturer in Chromatin Biology, Deputy Director of Manchester Breast Centre, University of Manchester
Thursday 19th June at 3pm BST / 4pm CET/ 10am EST
Discover how single-cell epigenomic technologies are enabling deeper insights into the epigenetic changes driving disease.
Talk 1: Using single cell technologies to assess chromatin
Sebastian Preissl, Professor and Head of Pharmacology & Toxicology, University of Graz
Talk 2: Single cell epigenomics: Computational tools and approaches
Michael Scherer, Group Leader, Division of Cancer Epigenomics, German Research Cancer Center DKFZ
Hosted by
Front Line Genomics is a genomics-focused media company, with a social mission to deliver the benefits of genomics to patients faster. We organise the Festival of Genomics, digital events and webinars. We also produce reports and operate a content-rich website.